Pro-Dex (PDEX) Receives Daily News Sentiment Score of 0.31

Headlines about Pro-Dex (NASDAQ:PDEX) have been trending positive on Tuesday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Pro-Dex earned a news impact score of 0.31 on Accern’s scale. Accern also gave news headlines about the medical instruments supplier an impact score of 45.889358806134 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Shares of Pro-Dex (PDEX) traded down $0.15 during mid-day trading on Tuesday, reaching $6.95. The company had a trading volume of 6,200 shares, compared to its average volume of 14,920. The stock has a market cap of $30.65, a P/E ratio of 5.47 and a beta of -0.30. Pro-Dex has a 1 year low of $4.30 and a 1 year high of $8.00.

ILLEGAL ACTIVITY NOTICE: “Pro-Dex (PDEX) Receives Daily News Sentiment Score of 0.31” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at

Pro-Dex Company Profile

Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.

Insider Buying and Selling by Quarter for Pro-Dex (NASDAQ:PDEX)

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit